Document is current
Any future updates will be listed below
-
Authors
Park, Sangwoo https://orcid.org/0000-0002-2701-3114
Maus, Marcela V. https://orcid.org/0000-0002-7578-0393
Choi, Bryan D.
-
Funding
Funding for this research was provided by:
Swim Across America, The Jenny Fund, A Shot for Life
Damon Runyon Cancer Research Foundation (DRG-2529-24)
- License Information
-
More Information
Article History
Received: 26 February 2024
Accepted: 30 October 2024
First Online: 19 December 2024
Competing interests
: M.V.M. is an inventor on patents related to adoptive cell therapies held by Massachusetts General Hospital (some licensed to Promab) and the University of Pennsylvania (some licensed to Novartis). M.V.M. holds equity in 2SeventyBio, Century Therapeutics, Neximmune, Oncternal, and TCR2, and has served as a consultant for multiple companies involved in cell therapies. M.V.M. is a member of the Board of Directors of 2SeventyBio. B.D.C. is an inventor of patents and patent applications relating to T-cell engineering approaches.
